Myrna Instrument & TriVerity Test

Sepsis, responsible for one in five global deaths, has likely touched the lives of everyone, either directly or indirectly. Each hour’s delay in treatment escalates mortality by 8%, underscoring the deadly consequences of slow and inaccurate diagnostics. We urgently need a rapid, precise diagnostic tool to transform outcomes, saving lives where every second counts in urgent care settings.

Inflammatix's TriVerity, a breakthrough in sepsis diagnostics, uses advanced AI and host response analysis for rapid, accurate identification of infection types and severity within 30 minutes. This pioneering technology cuts diagnostic times, enhances accuracy, and provides prognostic capabilities, ensuring timely treatment and reducing mortality risks in urgent care.

The Myrna Instrument and TriVerity test epitomize simplicity in a complex environment, designed for the high-stress settings of emergency departments. Its straightforward operation masks the sophisticated AI and host response technologies within. Operation is deceptively simple, streamlining complex processes to facilitate quick, accurate diagnostics. The device requires minimal interaction: a patient-drawn tube is inserted into a single-use cartridge, and the test begins with a single touch. An integrated barcode scanner efficiently handles multiple verifications—checking the test type, cartridge validity, sample ID, and expiration date. This device uniquely determines both the presence of infection and the severity of illness, offering crucial diagnostic and prognostic insights for managing sepsis.

The user interface, free from clutter, features intuitive prompts and animations, catering to different user preferences and highlighted with consistent design language for essential actions. The streamlined approach not only reduces cognitive load but also encapsulates all necessary supplies and waste within each consumable, enhancing safety and usability.

A (pre-approval) explanatory video can be found here.